

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PFE | NYSE | USD | Real-time | |
PFE | Mexico | MXN | Delayed | |
PFE | Stockholm | SEK | Real-time | |
PFE | Frankfurt | EUR | Delayed | |
PFE | TradeGate | EUR | Delayed | |
PFE | Hamburg | EUR | Delayed | |
PFE | Xetra | EUR | Delayed | |
PFE | Santiago | USD | Delayed | |
PFE | Buenos Aires | ARS | Delayed | |
PFIZ34 | BM&FBovespa | BRL | Delayed | |
PFE | Vienna | EUR | Delayed | |
PFE_KZ | KASE | USD | Delayed | |
PFE | Colombia | COP | Delayed | |
PFE | Lima | USD | Delayed |
Gilead Sciences (NASDAQ:GILD), Inc. GILD missed on earnings in the fourth quarter due to legal settlement charges. Sales from its antiviral COVID-19 treatment, Veklury (remdesivir) also...
Ed Yardeni has named the mega-cap companies that dominate the S&P 500 index, the “Mega-Cap 8.” This week we hear from Alphabet (NASDAQ:GOOGL) on Tuesday, February 1, Facebook (NASDAQ:FB) on Wednesday,...
The familiar litany heard from clients in the late 1990’s and lately today when the subject of trimming winners arises, particularly the Megacap 8 (as Ed Yardeni refers to the top market cap weights...
Pre-commercial biotech group Novavax’s stock is down more than 45% in January. The FDA has not yet authorized Novavax’s vaccine for use in the US. Long-term investors could consider buying...
Moderna (NASDAQ:MRNA)’s MRNA stock has seemingly bucked its strong uptrend since August last year as investors await another success from its pipeline. The stock has gained significantly since...
Tuesday, January 25, 2022 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features a real-time update on the ongoing Q4 earnings season, in...
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 21st:Pfizer PFE: This company that manufactures, markets, distributes, and sells...
Sanofi (NASDAQ:SNY) SNY and partner Regeneron (NASDAQ:REGN) REGN announced positive top-line data from the second pivotal phase III study on their blockbuster medicine Dupixent (dupilumab) for...
Despite the success of COVID vaccines and medicines, the biotech sector underperformed the broader market in 2021. The Medical-Biomedical and Genetics industry declined 21.6% in 2021 against the...
Leading off articles with a question sets the readers up for an expected answer which involves a prediction for the future. The fact is no one knows what will happen, and all clients can ask of...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review